Asthika Goonewardene
Stock Analyst at Truist Securities
(0)
# 4673
Out of 5,329 analysts
106
Total ratings
30.88%
Success rate
-20.17%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AUTL Autolus Therapeutics | Maintains: Buy | 11 10 | 1.34 | 646.27% | 4 | Apr 1, 2025 | |
GMAB Genmab | Maintains: Buy | 50 45 | 20.93 | 115% | 14 | Mar 11, 2025 | |
IOVA Iovance Biotherapeut... | Maintains: Buy | 25 15 | 3.35 | 347.76% | 6 | Mar 3, 2025 | |
CRGX Cargo Therapeutics | Downgrades: Hold | 32 7 | 4.38 | 59.82% | 3 | Jan 30, 2025 | |
EXEL Exelixis | Maintains: Strong Buy | 42 43 | 38.9 | 10.54% | 8 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 12 2 | 1.33 | 50.38% | 8 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 172 | 102.58 | 67.67% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 24.78 | 41.24% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 87 136 | 65.69 | 107.03% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 83 97 | 103.22 | -6.03% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 1.06 | 1315.09% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 17 14 | 1.7 | 723.53% | 6 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 44 | 8.63 | 409.85% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 88 | 34 | 158.82% | 1 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 69 88 | 45.4 | 93.83% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 4 | 1.51 | 164.9% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 19 | 0.8 | 2275% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 9 9 | 0.4 | 2150% | 3 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 229 | n/a | n/a | 4 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 | 1.34 | 2885.07% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 27 | 0.63 | 4185.71% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 15 18 | n/a | n/a | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Hold | 120 | 12.65 | 848.62% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 8 3 | n/a | n/a | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | n/a | n/a | 3 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 100 60 | 1.57 | 3721.66% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 15 | 0.48 | 3025% | 4 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 55 96 | n/a | n/a | 2 | Mar 3, 2020 |